International Clinical Trial: A Proof-of-concept Single-arm clinical trial Of semaglutide after withdrawal of biologic therapy for chronic plaque psoriasis in people with overweight/obesity (PSO-withdraw)

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ACTRN12626000951358) titled 'A Proof-of-concept Single-arm clinical trial Of semaglutide after withdrawal of biologic therapy for chronic plaque psoriasis in people with overweight/obesity (PSO-withdraw)' on Aug. 3.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Non-randomised trial Masking: Open (masking not used) Assignment: Single group

Primary Sponsor: Bayside Health

Condition: psoriasis obesity chronic plaque psoriasis psoriasis obesity chronic plaque psoriasis Diet and Nutrition - Obesity Skin - Dermatological conditions Inflammatory and Immune System - Autoimmune diseases

Intervention: In this study...